Navigation Links
I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process
Date:5/24/2012

LAKE FOREST, Ill., May 24, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today released a snapshot of the positive impact of I.V. clinical integration of infusion pumps and electronic health records (EHRs) in honor of Healthcare Technology Management Week, which recognizes the important work of healthcare technology professionals.

(Photo: http://photos.prnewswire.com/prnh/20120524/CG13208-INFO)

(Logo: http://photos.prnewswire.com/prnh/20040503/HSPLOGO)

"The I.V. clinical integration of infusion pumps with electronic health record systems has been shown to decrease the time it takes for nurses to start a new infusion by at least 27 percent,"[1] said Richard Nevin, vice president, Medication Management Systems, U.S., Hospira. "Using I.V. clinical integration to link a smart infusion pump with EHRs helps deliver the trifecta for hospitals: safety, efficiency and financial benefits."

The following multimedia assets provide additional information about how I.V. clinical integration can enhance patient safety, clinician workflow and cost prevention efforts:

  • Why I.V. Clinical Integration of Infusion Pumps is So Smart: This infographic illustrates the functionality and benefits of I.V. clinical integration with Hospira MedNet™ safety software, including visuals that reflect the number of steps that can be removed from the medication delivery process.
  • Symbiq™ Infusion Pump Overview Video: A quick look at Hospira's newly enhanced Symbiq device -- recently given the first general infusion pump clearance from the U.S. Food and Drug Administration (FDA) under the new 510(k) guidelines -- and the role it plays in I.V. clinical integration.
  • IVclinicalintegration.com: An online hub of visual resources, case studies and news about I.V. clinical integration.

Using I.V. clinical integration to integrate medication management technologies with EHRs enables seamless, near real-time sharing of patient and infusion information between the hospital's clinical information systems, medication pumps and other devices. Intravenous or I.V. medication administration is crucial to the health of patients, as 90 percent of hospital patients receive an infusion as part of their treatments, and 56 percent of all medication errors are associated with I.V. medications.[2],[3] Improving the process through clinical integration can help clinicians positively impact their patients' overall health and safety.

About Hospira

Hospira, Inc. is the world's leading provider of injectable drugs and infusion technologies. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 15,000 employees. Learn more at www.hospira.com.


[1] WellSpan Health. "WellSpan's collaborative efforts lead to Way-Paver," June 10, 2011, http://content.wellspan.org/breakingnews/default.aspx?pageID=11052, Accessed May 17, 2012.

[2] Hanchett, M. Visualizing the IV fluid path as an emerging concept in infection control. Infection Control Today. February 2004.

[3] Ross LM, Wallace J, Paton JY. Medication errors in a pediatric teaching hospital in the UK: five years operational experience. Arch Dis Child. 2000; 83(6);492-497

 


'/>"/>
SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology:
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... today at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra ... authored journal articles published in Emergency Medicine Practice and Pediatric Emergency ...
Breaking Medicine News(10 mins):